Editorial
 DISMAL SHOW BY GLOBAL PHARMA COS   
 Tuesday, April 26, 2016 
 The global pharmaceutical industry seems to be heading for a period of hard times looking at the performance figures of top 15 companies during 2015. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]CHMP recommends Roche’s Avastin in combo with Tarceva for patients with specific type of advanced lung cancer
17:00  [IST]EMA recommends marketing approval of Allergan's Enzepi for patients with exocrine pancreatic insufficiency
16:50  [IST]Apollo Hospitals inks MoU with Ontario's Osler to improve healthcare
16:00  [IST]EMA recommends expanded indication of Janssen's Imbruvica in previously untreated CLL
15:10  [IST]Lybrate launches online doctor consultation service on Facebook Messenger
15:00  [IST]Tecan introduces new MultiCheck QC package for GLP/GMP environments
more news >>
TOP NEWS
08:00  [IST]Union Ayush ministry issues draft Accreditation Standards for Ayurveda Hospitals
08:00  [IST]Experts fear India’s clinical research may get hit as global regulators spot irregularities
08:00  [IST]MSBB to file ABS non-compliance cases at JMFC court for recovery
08:00  [IST]TASUDMA seeks say in all spheres of policy making bodies under Ayush ministry
08:00  [IST]BMC to appoint 20 more counsellors for psychiatric help to TB patients in city
08:00  [IST]India, Mauritius sign MoU to promote cooperation in traditional medicine & homoeopathy
more news >>
YESTERDAY'S NEWS
18:00  [IST]Arrowhead Pharma seeks regulatory approval to begin phase 1/2 study of ARC-521 in HBV in New Zealand
17:00  [IST]RegeneRx, ReGenTree expand license for dry eye
16:00  [IST]CyTuVax reports positive interim results from phase I study of HBAI20 hepatitis B vaccine for non-responders
15:00  [IST]Quest Diagnostics' Zika RT-PCR test receives US FDA emergency use authorization
14:00  [IST]Color Genomics expands Color Test to 30 genes to assess risk of common hereditary cancers
13:00  [IST]twoXAR collaborates with Stanford University to support research on rare diseases medicine
more news >>
INTERVIEW  
Need for screening patients with high risk of aortic disease: Tony Semedo
Medtronic Tony Semedo, Senior vice president
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the ban on 344 FDC drugs by the Union Health Ministry came all of a sudden as is being argued by the industry?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |